Marwan Taha-Sheikh
Jbail, JL, Lebanon
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Prevalence and predictors of potentially inappropriate medication use among older adults with heart failure: a 2023 beers criteria-based evaluation.
Journal: BMC geriatrics
Published: January 09, 2026
Comparison of activated and 4-factor prothrombin complex concentrates for reversal of apixaban- and rivaroxaban-associated major bleeding.
Journal: Journal of thrombosis and thrombolysis
Published: November 07, 2025
The Use of Drugs that Should be Avoided or Used with Caution in Patients Hospitalized for Acute Decompensated Heart Failure.
Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions
Published: June 17, 2024
Efficacy and Safety of Activated Prothrombin Complex Concentrate for Reversal of the Anticoagulant Effect of Apixaban and Rivaroxaban in Patients with Major Bleeding.
Journal: Clinical drug investigation
Published: October 05, 2023
Polypharmacy and severe potential drug-drug interactions among older adults with cardiovascular disease in the United States.
Journal: BMC geriatrics
Published: November 16, 2020
Reversal of Apixaban and Rivaroxaban Using Activated Prothrombin Complex Concentrates in Patients with Major Bleeding.
Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions
Published: November 12, 2019
Non-activated prothrombin complex concentrates for major bleeding in patients on apixaban and rivaroxaban.
Journal: Internal and emergency medicine
Published: October 01, 2019
Reversal of dabigatran requiring hemodialysis, fresh frozen plasma, and 2 doses of idarucizumab in a patient with acute kidney injury.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
Published: August 06, 2019
Assessment of Non-vitamin K Oral Anticoagulants Use in a Tertiary Care Center in the USA: A Chart Review of 909 Patients.
Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions
Published: November 09, 2018
Idarucizumab for Reversal of Dabigatran: Single-Center Real-World Experience.
Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions
Published: September 12, 2018
Treatment of apixaban- and rivaroxaban-associated major bleeding using 4-factor prothrombin complex concentrate.
Journal: Internal and emergency medicine
Published: August 09, 2018
Last Updated: 09/26/2026